Open Access

Acute Calculous Cholecystitis Associated with Leptospirosis: Which is the Emergency? A Case Report and Literature Review

, , , , , , ,  and   
Jul 31, 2024

Cite
Download Cover

Fig. 1.

Acute calculous cholecystitis
Acute calculous cholecystitis

Fig. 2.

Platelet number (×103/μL)
Platelet number (×103/μL)

Fig. 3.

Total bilirubin and creatinine values during hospitalization (mg/dL)
Total bilirubin and creatinine values during hospitalization (mg/dL)

Fig. 4.

Magnetic resonance cholangiopancreatography (MRCP) imaging of the extrahepatic bile ducts
Magnetic resonance cholangiopancreatography (MRCP) imaging of the extrahepatic bile ducts

Changes in the patient’s laboratory parameters during hospitalization and six weeks after discharge

Two days before admission Admission day 1st day of treatment 2nd day of treatment 4th day of treatment 5th day of treatment 8th day of treatment Six weeks after discharge
Leucocyte (×103/μL) 9.61 8.79 6.08 5.69 10.90 16.60 10.32 6.42
Neutrophils (%) 89.70 86.80 89 83 78 78.7 80.10 57.6
Lymphocyte (%) 6.61 6.63 0.27 9.40 0.98 8.34 1.10 34.3
Hemoglobin (g/dL) 14.10 12.4 10.40 10.80 12.60 14.00 12.3 14.2
Hematocrit (%) 42.60 36.4 30.10 31.90 37.80 41.50 34.7 44.6
Thrombocyte (×103/μL) 155.00 28.5 14.00 12.90 31.60 * 28.90 * 130.00 241.00
AST (U/L) 25.00 75.00 78.00 123.00 48.00 45.60 91.80 24.00
ALT (U/L) 22.00 47.00 50.00 88.00 29.00 15.00 43.30 74.00
Total Bilirubin (mg/dL) 1.37 5.01 5.44 5.43 9.67 7.38 5.89 0.79
Direct Bilirubin (mg/dL) - 4.14 - - - 7.13 4.69 0.29
C-Reactive Protein (mg/dL) 143.20 291.40 252.30 - - 139.00 71.60 -
Urea (mg/dL) 34.24 115.56 128.40 186.18 196.88 169.00 104.00 53.00
Creatinine (mg/dL) 1.26 4.68 5.51 6.56 5.65 3.55 1.61 1.27
Calculated RFG (ml/min) 60.35 13.31 11.03 9.02 10.71 17.26 42.99 57.00
Amylase U/L 50.00 89.00 - 432.00 232.00 453.00 439.00 74.00

Ten cases of acute acalculous cholecystitis as a complication of leptospirosis [2, 4, 8,9,10,11,12,13,14]

Author V. Modesto dos Santos et al. [8] P. Davies et al. [2] D. A.R. Castelijn et al. [9] D. A.R. Castelijn et al. [9] H. Kilaru et al. [4] N. Tepelenis et al. [11] J. M. Villar et al. [12] J. Vishalakshi et al. [13] S. M.S Lim et al. [10] H. Diktas et al. [14]
Age 19 46 35 - 30 64 55 40 83 45
Sex F F F M M M M M M F
Country Brazil New Zealand Netherlands Netherlands India Greece Spain India Malaysia Turkey
Right hypochondrium or abdominal pain Yes Yes Yes Yes yes Yes Yes Yes Yes Yes
Jaundice No No No No Yes No Yes No No No
White blood cell number (×103/μL) 7.7 2.0 10.90 4.4 ND 14.00 27.1 12.30 11.70 7.30
Total bilirubin (mg/dL) ND ND 48 34 2.1 3.1 12.4 3.9 0.91 0.3
IgM titer ND ND ND ND Unequivocally positive Strongly positive Positive Positive Positive Positive
Thrombocytopenia (/μL) Yes (145,000) Yes (84,000) No (121,000) No (121,000) Yes (65,000) Yes (95,000) Yes (57,000) Yes (85,000) No (169,000) No (316,000)
Imaging modalities Abdominal ultrasound and CT Abdominal ultrasound and MRCP Abdominal ultrasound Abdominal ultrasound Abdominal ultrasound Abdominal ultrasound and CT CT Abdominal ultrasound CT Abdominal ultrasound
Imaging findings for acute cholecystitis Yes Yes Yes Yes No Yes Yes Yes Yes Yes
Gallbladder stones AAC AAC AAC AAC AAC AAC AAC ACC ACC ACC
Renal failure No No No No No Yes Yes Yes Yes No
Associated pancreatitis or pancreatic reaction No No no No No No No No Yes No
Treatment Antibiotics Antibiotics Antibiotics Antibiotics Antibiotics and open cholecystectomy Antibiotics and open cholecystectomy Antibiotics Antibiotics Antibiotics Antibiotics
Complications Pneumonia, Pericarditis - Pneumonia Pneumonia - Chronic renal failure Multiorgan failure, death - - -